Abstract
A number of new treatments have been approved for patients with multiple myeloma (MM) and the survival of patients continues to improve. However, discrepancies in outcomes of clinical trials and th...
Keywords
Funding Information
  • Takeda
  • National Institute for Health Research University College London Hospitals Biomedical Research Centre

This publication has 9 references indexed in Scilit: